610 related articles for article (PubMed ID: 25529048)
1. The influence of the human microbiome and probiotics on cardiovascular health.
Ettinger G; MacDonald K; Reid G; Burton JP
Gut Microbes; 2014; 5(6):719-28. PubMed ID: 25529048
[TBL] [Abstract][Full Text] [Related]
2. Metabolic endotoxemia and cardiovascular disease: A systematic review about potential roles of prebiotics and probiotics.
Moludi J; Maleki V; Jafari-Vayghyan H; Vaghef-Mehrabany E; Alizadeh M
Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):927-939. PubMed ID: 31894861
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular benefits of probiotics: a review of experimental and clinical studies.
Thushara RM; Gangadaran S; Solati Z; Moghadasian MH
Food Funct; 2016 Feb; 7(2):632-42. PubMed ID: 26786971
[TBL] [Abstract][Full Text] [Related]
4. 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk.
Tuohy KM; Fava F; Viola R
Proc Nutr Soc; 2014 May; 73(2):172-85. PubMed ID: 24495527
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Diseases of Developmental Origins: Preventive Aspects of Gut Microbiota-Targeted Therapy.
Hsu CN; Hou CY; Hsu WH; Tain YL
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371800
[TBL] [Abstract][Full Text] [Related]
6. Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder.
Luqman A; Hassan A; Ullah M; Naseem S; Ullah M; Zhang L; Din AU; Ullah K; Ahmad W; Wang G
Front Immunol; 2024; 15():1321395. PubMed ID: 38343539
[TBL] [Abstract][Full Text] [Related]
7. Clinical Evidence on the Potential Beneficial Effects of Probiotics and Prebiotics in Cardiovascular Disease.
Pavlidou E; Fasoulas A; Mantzorou M; Giaginis C
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555535
[TBL] [Abstract][Full Text] [Related]
8. Role of Gut Microbiota, Probiotics and Prebiotics in the Cardiovascular Diseases.
Oniszczuk A; Oniszczuk T; Gancarz M; Szymańska J
Molecules; 2021 Feb; 26(4):. PubMed ID: 33671813
[TBL] [Abstract][Full Text] [Related]
9. Functional food addressing heart health: do we have to target the gut microbiota?
Ryan PM; Ross RP; Fitzgerald GF; Caplice NM; Stanton C
Curr Opin Clin Nutr Metab Care; 2015 Nov; 18(6):566-71. PubMed ID: 26406391
[TBL] [Abstract][Full Text] [Related]
10. Archaebiotics: proposed therapeutic use of archaea to prevent trimethylaminuria and cardiovascular disease.
Brugère JF; Borrel G; Gaci N; Tottey W; O'Toole PW; Malpuech-Brugère C
Gut Microbes; 2014; 5(1):5-10. PubMed ID: 24247281
[TBL] [Abstract][Full Text] [Related]
11. Circulating bile acids as a link between the gut microbiota and cardiovascular health: impact of prebiotics, probiotics and polyphenol-rich foods.
Pushpass RG; Alzoufairi S; Jackson KG; Lovegrove JA
Nutr Res Rev; 2022 Dec; 35(2):161-180. PubMed ID: 33926590
[TBL] [Abstract][Full Text] [Related]
12. Probiotics as Beneficial Dietary Supplements to Prevent and Treat Cardiovascular Diseases: Uncovering Their Impact on Oxidative Stress.
Vasquez EC; Pereira TMC; Peotta VA; Baldo MP; Campos-Toimil M
Oxid Med Cell Longev; 2019; 2019():3086270. PubMed ID: 31205584
[TBL] [Abstract][Full Text] [Related]
13. Archaea, specific genetic traits, and development of improved bacterial live biotherapeutic products: another face of next-generation probiotics.
Fadhlaoui K; Arnal ME; Martineau M; Camponova P; Ollivier B; O'Toole PW; Brugère JF
Appl Microbiol Biotechnol; 2020 Jun; 104(11):4705-4716. PubMed ID: 32281023
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications.
Jones ML; Tomaro-Duchesneau C; Martoni CJ; Prakash S
Expert Opin Biol Ther; 2013 May; 13(5):631-42. PubMed ID: 23350815
[TBL] [Abstract][Full Text] [Related]
15. Trimethylamine/Trimethylamine-N-Oxide as a Key Between Diet and Cardiovascular Diseases.
He S; Jiang H; Zhuo C; Jiang W
Cardiovasc Toxicol; 2021 Aug; 21(8):593-604. PubMed ID: 34003426
[TBL] [Abstract][Full Text] [Related]
16. Understanding connections and roles of gut microbiome in cardiovascular diseases.
Rajendiran E; Ramadass B; Ramprasath V
Can J Microbiol; 2021 Feb; 67(2):101-111. PubMed ID: 33079568
[TBL] [Abstract][Full Text] [Related]
17. The role of probiotics on each component of the metabolic syndrome and other cardiovascular risks.
Miglioranza Scavuzzi B; Miglioranza LH; Henrique FC; Pitelli Paroschi T; Lozovoy MA; Simão AN; Dichi I
Expert Opin Ther Targets; 2015; 19(8):1127-38. PubMed ID: 25872805
[TBL] [Abstract][Full Text] [Related]
18. Applications of Strain-Specific Probiotics in the Management of Cardiovascular Diseases: A Systemic Review.
Khan S; Ahmad F; Khalid N
Mol Nutr Food Res; 2024 Apr; 68(8):e2300675. PubMed ID: 38549453
[TBL] [Abstract][Full Text] [Related]
19. Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism.
Pathak P; Helsley RN; Brown AL; Buffa JA; Choucair I; Nemet I; Gogonea CB; Gogonea V; Wang Z; Garcia-Garcia JC; Cai L; Temel R; Sangwan N; Hazen SL; Brown JM
Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1474-H1486. PubMed ID: 32330092
[TBL] [Abstract][Full Text] [Related]
20. Effects of probiotics on body adiposity and cardiovascular risk markers in individuals with overweight and obesity: A systematic review and meta-analysis of randomized controlled trials.
Pontes KSDS; Guedes MR; Cunha MRD; Mattos SS; Barreto Silva MI; Neves MF; Marques BCAA; Klein MRST
Clin Nutr; 2021 Aug; 40(8):4915-4931. PubMed ID: 34358838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
